Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BRISTOL MYERS SQUIBB CO | Director | Deferred Share Units | 27.3K | $1.33M | $48.67 | Feb 1, 2024 | Direct |
EYENOVIA, INC. | Director | Common Stock, par value $.0001 | 30.4K | $41.4K | $1.36 | Jun 16, 2022 | Direct |
EYENOVIA, INC. | Director | Stock Option (right to buy) | 30.8K | Jun 16, 2022 | Direct | ||
Outlook Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.1K | Oct 3, 2024 | Direct |